UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Identification of nagilactone E as a protein synthesis inhibitor with anticancer activity Journal article
Zhang,Le le, Guo,Jing, Jiang,Xiao ming, Chen,Xiu ping, Wang,Yi tao, Li,Ao, Lin,Li gen, Li,Hua, Lu,Jin jian. Identification of nagilactone E as a protein synthesis inhibitor with anticancer activity[J]. Acta Pharmacologica Sinica, 2020, 41(5), 698-705.
Authors:  Zhang,Le le;  Guo,Jing;  Jiang,Xiao ming;  Chen,Xiu ping;  Wang,Yi tao; et al.
Favorite | TC[WOS]:14 TC[Scopus]:14  IF:6.9/7.6 | Submit date:2021/03/01
Nagilactone e  Diterpenoids  Human Lung Cancer A549 Cell Line Xenograft  Rna-seq  Cmap  Click-it  Molecular Docking  Riok2  Protein Synthesis Inhibitor  
Effects of Coptis extract combined with chemotherapeutic agents on ROS production, multidrug resistance, and cell growth in A549 human lung cancer cells Journal article
He C., Rong R., Liu J., Wan J., Zhou K., Kang J.X.. Effects of Coptis extract combined with chemotherapeutic agents on ROS production, multidrug resistance, and cell growth in A549 human lung cancer cells[J]. Chinese Medicine, 2012, 7.
Authors:  He C.;  Rong R.;  Liu J.;  Wan J.;  Zhou K.; et al.
Favorite | TC[WOS]:26 TC[Scopus]:26 | Submit date:2018/12/28
A549 Cell  Reactive Oxygen Species Production  Reactive Oxygen Species Level  Berberine  Fulvestrant